179 related articles for article (PubMed ID: 2333292)
1. Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.
Leiter JM; Agrawal S; Palese P; Zamecnik PC
Proc Natl Acad Sci U S A; 1990 May; 87(9):3430-4. PubMed ID: 2333292
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antiviral activity of antisense oligonucleotides against influenza virus].
Chen Z; Wang S; Guan W; Yang B; Sun Z
Wei Sheng Wu Xue Bao; 2000 Oct; 40(5):482-7. PubMed ID: 12548758
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
[TBL] [Abstract][Full Text] [Related]
4. Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus.
Kim SG; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1991 Sep; 179(3):1614-9. PubMed ID: 1930201
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
Matsukura M; Zon G; Shinozuka K; Stein CA; Mitsuya H; Cohen JS; Broder S
Gene; 1988 Dec; 72(1-2):343-7. PubMed ID: 3243433
[TBL] [Abstract][Full Text] [Related]
6. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
Matsukura M; Shinozuka K; Zon G; Mitsuya H; Reitz M; Cohen JS; Broder S
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7706-10. PubMed ID: 3499613
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo anti-influenza A virus activity of antisense oligonucleotides.
Abe T; Mizuta T; Suzuki S; Hatta T; Takai K; Yokota T; Takaku H
Nucleosides Nucleotides; 1999; 18(6-7):1685-8. PubMed ID: 10474246
[TBL] [Abstract][Full Text] [Related]
8. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
[TBL] [Abstract][Full Text] [Related]
9. Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.
Agrawal S; Goodchild J; Civeira MP; Thornton AH; Sarin PS; Zamecnik PC
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7079-83. PubMed ID: 3174622
[TBL] [Abstract][Full Text] [Related]
10. Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry.
Luganini A; Caposio P; Landolfo S; Gribaudo G
Antimicrob Agents Chemother; 2008 Mar; 52(3):1111-20. PubMed ID: 18180342
[TBL] [Abstract][Full Text] [Related]
11. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mouse hepatitis virus multiplication by phosphorothioate analogues of oligodeoxynucleotides complementary to the leader RNA.
Hayashi M; Maeda A; Watanabe T; Hanaki K; Arai S; Nozaki S
J Vet Med Sci; 1995 Dec; 57(6):1081-3. PubMed ID: 8720052
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides.
Kwok T; Helfer H; Alam MI; Heinrich J; Pavlovic J; Moelling K
Arch Virol; 2009; 154(1):109-14. PubMed ID: 19034603
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by unmodified, phosphorothioated, and liposomally encapsulated oligonucleotides.
Hatta T; Nakagawa Y; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1996 Jun; 223(2):341-6. PubMed ID: 8670284
[TBL] [Abstract][Full Text] [Related]
16. Cellular uptake and biological effects of antisense oligodeoxynucleotide analogs targeted to herpes simplex virus.
Shoji Y; Shimada J; Mizushima Y; Iwasawa A; Nakamura Y; Inouye K; Azuma T; Sakurai M; Nishimura T
Antimicrob Agents Chemother; 1996 Jul; 40(7):1670-5. PubMed ID: 8807060
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells.
Abe T; Suzuki S; Hatta T; Takai K; Yokota T; Takaku H
Antivir Chem Chemother; 1998 May; 9(3):253-62. PubMed ID: 9875404
[TBL] [Abstract][Full Text] [Related]
18. Oligonucleotides derived from the packaging signal at the 5' end of the viral PB2 segment specifically inhibit influenza virus in vitro.
Giannecchini S; Clausi V; Nosi D; Azzi A
Arch Virol; 2009; 154(5):821-32. PubMed ID: 19370391
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of restriction endonuclease cleavage site via triple helix formation by homopyrimidine phosphorothioate oligonucleotides.
Tsukahara S; Kim SG; Takaku H
Biochem Biophys Res Commun; 1993 Oct; 196(2):990-6. PubMed ID: 8240378
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
